Literature DB >> 22588773

Measures of fibromyalgia: Fibromyalgia Impact Questionnaire (FIQ), Brief Pain Inventory (BPI), Multidimensional Fatigue Inventory (MFI-20), Medical Outcomes Study (MOS) Sleep Scale, and Multiple Ability Self-Report Questionnaire (MASQ).

David A Williams1, Lesley M Arnold.   

Abstract

Entities:  

Mesh:

Year:  2011        PMID: 22588773      PMCID: PMC3527080          DOI: 10.1002/acr.20531

Source DB:  PubMed          Journal:  Arthritis Care Res (Hoboken)        ISSN: 2151-464X            Impact factor:   4.794


× No keyword cloud information.
  51 in total

1.  A randomized, double-blind, placebo-controlled trial of duloxetine in the treatment of women with fibromyalgia with or without major depressive disorder.

Authors:  Lesley M Arnold; Amy Rosen; Yili Lu Pritchett; Deborah N D'Souza; David J Goldstein; Smriti Iyengar; Joachim F Wernicke
Journal:  Pain       Date:  2005-11-17       Impact factor: 6.961

2.  The Fibromyalgia Impact Questionnaire (FIQ): a review of its development, current version, operating characteristics and uses.

Authors:  R Bennett
Journal:  Clin Exp Rheumatol       Date:  2005 Sep-Oct       Impact factor: 4.473

3.  Defining the clinically important difference in pain outcome measures.

Authors:  J T Farrar; R K Portenoy; J A Berlin; J L Kinman; B L Strom
Journal:  Pain       Date:  2000-12-01       Impact factor: 6.961

4.  Efficacy and safety of milnacipran 100 mg/day in patients with fibromyalgia: results of a randomized, double-blind, placebo-controlled trial.

Authors:  Lesley M Arnold; R Michael Gendreau; Robert H Palmer; Judy F Gendreau; Yong Wang
Journal:  Arthritis Rheum       Date:  2010-09

5.  Development of the Wisconsin Brief Pain Questionnaire to assess pain in cancer and other diseases.

Authors:  R L Daut; C S Cleeland; R C Flanery
Journal:  Pain       Date:  1983-10       Impact factor: 6.961

6.  Identifying the clinical domains of fibromyalgia: contributions from clinician and patient Delphi exercises.

Authors:  Phillip J Mease; Lesley M Arnold; Leslie J Crofford; David A Williams; I Jon Russell; Louise Humphrey; Linda Abetz; Susan A Martin
Journal:  Arthritis Rheum       Date:  2008-07-15

7.  Assessment of fatigue in patients with fibromyalgia and chronic widespread pain. Reliability and validity of the Swedish version of the MFI-20.

Authors:  Anna Ericsson; Kaisa Mannerkorpi
Journal:  Disabil Rehabil       Date:  2007-11-30       Impact factor: 3.033

8.  A 14-week, randomized, double-blinded, placebo-controlled monotherapy trial of pregabalin in patients with fibromyalgia.

Authors:  Lesley M Arnold; I Jon Russell; E W Diri; W Rachel Duan; James P Young; Uma Sharma; Susan A Martin; Jeannette A Barrett; George Haig
Journal:  J Pain       Date:  2008-06-03       Impact factor: 5.820

9.  The efficacy and safety of milnacipran for treatment of fibromyalgia. a randomized, double-blind, placebo-controlled trial.

Authors:  Philip J Mease; Daniel J Clauw; R Michael Gendreau; Srinivas G Rao; Jay Kranzler; Wei Chen; Robert H Palmer
Journal:  J Rheumatol       Date:  2009-02       Impact factor: 4.666

10.  Minimal clinically important difference in the fibromyalgia impact questionnaire.

Authors:  Robert M Bennett; Andrew G Bushmakin; Joseph C Cappelleri; Gergana Zlateva; Alesia B Sadosky
Journal:  J Rheumatol       Date:  2009-04-15       Impact factor: 4.666

View more
  39 in total

1.  Patients With Fibromyalgia Have Significant Autonomic Symptoms But Modest Autonomic Dysfunction.

Authors:  Ann Vincent; Mary O Whipple; Phillip A Low; Michael Joyner; Tanya L Hoskin
Journal:  PM R       Date:  2015-08-24       Impact factor: 2.298

2.  A Comparison of Fibromyalgia Symptoms in Patients with Healthy versus Depressive, Low and Reactive Affect Balance Styles.

Authors:  Loren L Toussaint; Ann Vincent; Samantha J McAllister; Terry H Oh; Afton L Hassett
Journal:  Scand J Pain       Date:  2014-07-01

3.  Validation and cross-cultural adaptation of the 'Fibromyalgia Participation Questionnaire' to the Spanish population: study protocol.

Authors:  M Gomez-Calvente; I Medina-Porqueres; A Fontalba-Navas; J M Pena-Andreu; C de Vos-Martin
Journal:  Rheumatol Int       Date:  2015-04-07       Impact factor: 2.631

4.  Neurocognitive complaints and functional status among patients with chronic fatigue syndrome and fibromyalgia.

Authors:  Karen B Schmaling; Karran L Betterton
Journal:  Qual Life Res       Date:  2015-10-15       Impact factor: 4.147

Review 5.  Patient-Reported Outcomes in Psoriatic Arthritis.

Authors:  Ana-Maria Orbai; Alexis Ogdie
Journal:  Rheum Dis Clin North Am       Date:  2016-03-16       Impact factor: 2.670

6.  Development and initial validation of a brief self-report measure of cognitive dysfunction in fibromyalgia.

Authors:  Anna L Kratz; Stephen G Schilling; Jenna Goesling; David A Williams
Journal:  J Pain       Date:  2015-03-04       Impact factor: 5.820

7.  Discordant Dry Eye Disease (An American Ophthalmological Society Thesis).

Authors:  Roni M Shtein; Daniel E Harper; Vincent Pallazola; Steven E Harte; Munira Hussain; Alan Sugar; David A Williams; Daniel J Clauw
Journal:  Trans Am Ophthalmol Soc       Date:  2016-08

8.  Understanding the Association of Fatigue With Other Symptoms of Fibromyalgia: Development of a Cluster Model.

Authors:  Nada Lukkahatai; Brian Walitt; Alexandra Espina; Alves Gelio; Leorey N Saligan
Journal:  Arthritis Care Res (Hoboken)       Date:  2016-01       Impact factor: 4.794

Review 9.  Patient-Reported Outcomes and Fibromyalgia.

Authors:  David A Williams; Anna L Kratz
Journal:  Rheum Dis Clin North Am       Date:  2016-03-17       Impact factor: 2.670

10.  Psychometric properties of scale constructed from the International Classification of Functioning, Disability and Health (ICF) core set for breast cancer based on Rasch analysis.

Authors:  Eun Joo Yang; Eun-Kyoung Shin; Hyung-Ik Shin; Jae-Young Lim
Journal:  Support Care Cancer       Date:  2014-05-13       Impact factor: 3.603

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.